Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Freenome, Inc (FRNM : NSDQ)

• Company Description    Freenome Holdings Inc. is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome Holdings Inc., formerly known as Perceptive Capital Solutions Corp., is based in BRISBANE, Calif. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $13.63 Daily Weekly Monthly 20 Day Moving Average: 925,782 shares Shares Outstanding: 8.16 (millions) Market Capitalization: $111.18 (millions) Beta: 0.35 52 Week High: $14.26 52 Week Low: $9.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.73% 0.92% 12 Week 21.59% 18.63% Year To Date 4.60% -7.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 51 ASTOR PLACE 10TH FLOOR - NEW YORK,NY 10003 USA ph: 212-284-2300 fax: - None http://www.perceptivelife.com/pcsc

• General Corporate Information    Officers Adam Stone - Chief Executive Officer Joseph Edelman - Chairman Sam Cohn - Chief Financial Officer Mark C. McKenna - Director Kenneth Song - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 35661P100 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 8.16 Most Recent Split Date: (:1) Beta: 0.35 Market Capitalization: $111.18 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 145.11 Price / Sales: - EPS Growth vs. Year Ago Period: -114.29% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - -2.70 12/31/25 - -26.70 ROA 06/30/26 - -0.84 03/31/26 - 0.12 12/31/25 - 0.91 Current Ratio 06/30/26 - 0.20 03/31/26 - 0.23 12/31/25 - 0.40 Quick Ratio 06/30/26 - 0.20 03/31/26 - 0.23 12/31/25 - 0.40 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - -0.77 03/31/26 - -0.63 12/31/25 - -0.54 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©